HLA studies of endemic african kaposi's sarcoma patients and matched controls: No association with hla‐DR5

Research output: Contribution to journalJournal articleResearchpeer-review

  • Mads Melbye
  • Luc Kestens
  • Paul L. Gigase
  • Robert J. Biggar
  • Geziena M.T. Schreuder

In the search for a genetic factor involved in the etiology of Kaposi's sarcoma, several studies have recently focused on a significantly increased HLA determinant, DR5, as well as a decreased DR3, among patients with both the classical and the AIDS‐related form of Kaposi's sarcoma. To test the consistency of this phenomenon, we analysed the frequencies of HLA immunogenetic markers in 23 histologically confirmed Kaposi's sarcoma patients from Central Africa, where this tumor is endemic, and a local sex‐ and tribe‐matched control group. No definite association was observed for any of the HLA antigens, including DR5 and DR3. We were not able to support the hypothesis that the same HLA‐associated immune susceptibility factors are involved in all types of Kaposi's sarcoma.

Original languageEnglish
JournalInternational Journal of Cancer
Volume39
Issue number2
Pages (from-to)182-184
Number of pages3
ISSN0020-7136
DOIs
Publication statusPublished - 15 Feb 1987

ID: 260893137